Kuehn Law, PLLC, is investigating whether certain officers and directors of Quantum Computing Inc. violated their fiduciary duties through potential self-dealing. The probe could lead to shareholder damages and corporate governance reforms. Earlier records identified Rhythm Pharmaceuticals, Inc. and TG Therapeutics, Inc., indicating that the company named in the notices has changed or remains inconsistent across releases. The earlier Rhythm notice identified Nasdaq ticker RYTM, urged long-term shareholders to contact Justin Kuehn, Esq., and said the consultation and case were free, with limited time potentially available to enforce rights.